Cargando…

Breastfeeding prevalence in newborns of mothers with COVID-19: a systematic review

OBJECTIVES: to compare exclusive breastfeeding prevalence versus artificial feeding in newborns of mothers with COVID-19. METHODS: a systematic review of prevalence, according to JBI. Searches in PubMe(d)®, Embase, CINAHL, LILACS and Web of Science™ databases in August 2021. Cross-sectional, longitu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruiz, Mariana Torreglosa, de Oliveira, Karoline Faria, Azevedo, Nayara Freitas, Paschoini, Marina Carvalho, Rodrigues, Wellington Francisco, de Oliveira, Carlo José Freire, de Oliveira, Jacqueline Faria, Fonseca, Luciana Mara Monti, Wernet, Monika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Enfermagem 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389650/
https://www.ncbi.nlm.nih.gov/pubmed/37531480
http://dx.doi.org/10.1590/0034-7167-2022-0173
Descripción
Sumario:OBJECTIVES: to compare exclusive breastfeeding prevalence versus artificial feeding in newborns of mothers with COVID-19. METHODS: a systematic review of prevalence, according to JBI. Searches in PubMe(d)®, Embase, CINAHL, LILACS and Web of Science™ databases in August 2021. Cross-sectional, longitudinal or cohort studies were selected, without language and time limitations that showed breastfeeding prevalence or that allowed calculation. RESULTS: fifteen articles published in 2020 and 2021, cohort (60%) or cross-sectional (40%) were analyzed. The average of exclusive breastfeeding in mothers with COVID-19 was 56.76% (CI=39.90–72.88), and artificial breastfeeding, 43.23% (CI = 30.99 – 55.88), without statistically significant differences. CONCLUSIONS: despite the recommendations for maintaining breastfeeding, there was a reduction worldwide, when compared to periods prior to the pandemic. With advances in science, these rates have improved, showing the impact of evidence on practices. As limitations, study sources are cited. It is recommended to carry out new studies. PROSPERO registration CRD42021234486.